The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression (original) (raw)

• Adiseshaiah P, Peddakama S, Zhang Q, Kalvakolanu DV, Reddy SP . (2005). Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Oncogene 24: 4193–4205.
  Article CAS PubMed Google Scholar
• Allavena P, Sica A, Solinas G, Porta C, Mantovani A . (2008). The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1–9.
  Article PubMed Google Scholar
• Asschert JG, de Vries EG, De JS, Withoff S, Vellenga E . (1999). Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1. Int J Cancer 81: 236–242.
  Article CAS PubMed Google Scholar
• Balkwill F, Charles KA, Mantovani A . (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211–217.
  Article CAS PubMed Google Scholar
• Bronte V, Zanovello P . (2005). Regulation of immune responses by l-arginine metabolism. Nat Rev Immunol 5: 641–654.
  Article CAS PubMed Google Scholar
• Condeelis J, Pollard JW . (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263–266.
  Article CAS PubMed Google Scholar
• Coussens LM, Tinkle CL, Hanahan D, Werb Z . (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481–490.
  Article CAS PubMed PubMed Central Google Scholar
• Darnell Jr JE . (2002). Transcription factors as targets for cancer therapy. Nat Rev Cancer 2: 740–749.
  Article CAS PubMed Google Scholar
• Faggioli L, Costanzo C, Donadelli M, Palmieri M . (2004). Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim Biophys Acta 1692: 17–24.
  Article CAS PubMed Google Scholar
• Fraser CC, Chen BP, Webb S, van RN, Kraal G . (1995). Circulation of human hematopoietic cells in severe combined immunodeficient mice after Cl2MDP-liposome-mediated macrophage depletion. Blood 86: 183–192.
  CAS PubMed Google Scholar
• Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL et al. (2007). Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 117: 3846–3856.
  Article CAS PubMed PubMed Central Google Scholar
• Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP . (2005). Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 65: 3437–3446.
  Article CAS PubMed Google Scholar
• Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C . (2004). Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25: 1543–1549.
  Article CAS PubMed Google Scholar
• Hiratsuka S, Watanabe A, Aburatani H, Maru Y . (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369–1375.
  Article CAS PubMed Google Scholar
• Hodge DR, Hurt EM, Farrar WL . (2005). The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41: 2502–2512.
  Article CAS PubMed Google Scholar
• Knudsen E, Iversen PO, van RN, Benestad HB . (2002). Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat. Eur J Haematol 69: 284–296.
  Article CAS PubMed Google Scholar
• Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S et al. (2005). Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11: 1314–1321.
  Article CAS PubMed Google Scholar
• Kortylewski M, Yu H . (2008). Role of Stat3 in suppressing anti-tumor immunity. Curr Opin Immunol 20: 228–233.
  Article CAS PubMed PubMed Central Google Scholar
• Leek RD, Harris AL . (2002). Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7: 177–189.
  Article PubMed Google Scholar
• Lewen S, Zhou H, Hu HD, Cheng T, Markowitz D, Reisfeld RA et al. (2008). A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunol Immunother 57: 507–515.
  Article CAS PubMed Google Scholar
• Lewis CE, Pollard JW . (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605–612.
  Article CAS PubMed Google Scholar
• Lin EY, Li JF, Bricard G, Wang W, Deng Y, Sellers R et al. (2007). Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol 1: 288–302.
  Article PubMed PubMed Central Google Scholar
• Lin EY, Nguyen AV, Russell RG, Pollard JW . (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727–740.
  Article CAS PubMed PubMed Central Google Scholar
• Lin EY, Pollard JW . (2007). Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67: 5064–5066.
  Article CAS PubMed Google Scholar
• Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C et al. (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116: 2132–2141.
  Article CAS PubMed PubMed Central Google Scholar
• Mantovani A, Schioppa T, Porta C, Allavena P, Sica A . (2006). Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25: 315–322.
  Article PubMed Google Scholar
• Martinez FO, Sica A, Mantovani A, Locati M . (2008). Macrophage activation and polarization. Front Biosci 13: 453–461.
  Article CAS PubMed Google Scholar
• Milde-Langosch K . (2005). The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 41: 2449–2461.
  Article CAS PubMed Google Scholar
• Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H et al. (1998). FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol 12: 973–985.
  Article CAS PubMed Google Scholar
• Pollard JW . (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71–78.
  Article CAS PubMed Google Scholar
• Sica A, Schioppa T, Mantovani A, Allavena P . (2006). Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717–727.
  Article CAS PubMed Google Scholar
• van RN . (1989). The liposome-mediated macrophage ‘suicide’ technique. J Immunol Methods 124: 1–6.
  Article Google Scholar
• van RN, Sanders A . (1994). Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83–93.
  Article Google Scholar
• Yu H, Kortylewski M, Pardoll D . (2007). Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7: 41–51.
  Article CAS PubMed Google Scholar
• Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A et al. (2001). Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61: 5168–5178.
  CAS PubMed Google Scholar
• Zerbini LF, Wang Y, Cho JY, Libermann TA . (2003). Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res 63: 2206–2215.
  CAS PubMed Google Scholar